L Bendtsen Selected Research

Tension-Type Headache (Tension Headache)

1/2010	Guidelines for controlled trials of drugs in tension-type headache: second edition.
3/2009	Memantine for prophylaxis of chronic tension-type headache--a double-blind, randomized, crossover clinical trial.
2/2007	Combination of low-dose mirtazapine and ibuprofen for prophylaxis of chronic tension-type headache.
10/2006	A prospective, open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache.
11/2004	Glyceryl trinitrate may trigger endogenous nitric oxide production in patients with chronic tension-type headache.
6/2004	Possible mechanisms of pain perception in patients with episodic tension-type headache. A new experimental model of myofascial pain.
3/2003	Tender points are not sites of ongoing inflammation -in vivo evidence in patients with chronic tension-type headache.
2/2002	In vivo evidence of altered skeletal muscle blood flow in chronic tension-type headache.
3/2001	Calcitonin gene-related peptide levels during nitric oxide-induced headache in patients with chronic tension-type headache.
12/2000	Possible mechanisms of glyceryl-trinitrate-induced immediate headache in patients with chronic tension-type headache.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L Bendtsen Research Topics

Disease

15	Tension-Type Headache (Tension Headache) 01/2010 - 01/2000
10	Headache (Headaches) 02/2016 - 06/2000
5	Pain (Aches) 01/2019 - 01/2000
5	Migraine Disorders (Migraine) 05/2014 - 05/2000
2	Chronic Pain 03/2009 - 01/2000
2	Myalgia 12/2008 - 07/2000
1	Secondary Headache Disorders 11/2010
1	Cluster Headache (Cluster Headaches) 11/2000
1	Headache Disorders (Headache Syndromes) 01/2000

Drug/Important Bio-Agent (IBA)

5	Analgesics (Analgesic Drugs)IBA 02/2016 - 01/2000
5	Nitroglycerin (Dynamite)FDA LinkGeneric 12/2007 - 09/2000
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2004 - 09/2000
3	Calcitonin Gene-Related PeptideIBA 03/2001 - 05/2000
2	Glutamic Acid (Glutamate)FDA Link 12/2008 - 03/2003
2	BradykininIBA 06/2004 - 03/2003
2	Dinoprostone (PGE2)FDA Link 06/2004 - 03/2003
2	Serotonin (5 Hydroxytryptamine)IBA 06/2004 - 06/2000
2	Nitric Oxide Synthase (NO Synthase)IBA 12/2000 - 01/2000
2	Citalopram FDA LinkGeneric 07/2000 - 06/2000
2	Amitriptyline (Elavil)FDA LinkGeneric 07/2000 - 06/2000
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2019
1	fosphenytoin (Cerebyx)FDA LinkGeneric 01/2019
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 05/2014
1	Pharmaceutical PreparationsIBA 01/2010
1	N-Methylaspartate (NMDA)IBA 03/2009
1	Memantine (Namenda)FDA Link 03/2009
1	Mirtazapine (Rexer)FDA LinkGeneric 02/2007
1	Ibuprofen (Motrin)FDA LinkGeneric 02/2007
1	Topiramate (Topamax)FDA LinkGeneric 10/2006
1	Arginine (L-Arginine)FDA Link 11/2004
1	Histamine (Histamine Dihydrochloride)FDA Link 06/2004
1	Adenosine (Adenocard)FDA LinkGeneric 03/2003
1	Adenosine Triphosphate (ATP)IBA 03/2003
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2002
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 07/2000
1	omega-N-Methylarginine (NG Monomethyl L Arginine)IBA 01/2000

Therapy/Procedure

3	Intravenous Infusions 01/2019 - 09/2000
1	Aftercare (After-Treatment) 05/2014
1	Drug Therapy (Chemotherapy) 01/2010
1	Therapeutics 02/2007